dupilumab
regeneron,sanofi
['eosinophilic,esophagitis', 'sanofi', 'regeneron']
we re presenting late-breaking phase 3 data with for our medicine in children aged 1 to 11 years with eosinophilic esophagitis, a chronic disease that can make it difficult to swallow food. learn more at #uegweek:
Official channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here https://t.co/EuFDUdQQ5E